Multinational study confirms human papillomaviruses (HPV)-cervical cancer link
This article was originally published in Clinica
Executive Summary
More than nine out of ten cases of cervical cancer are caused by human papillomaviruses (HPV). According to a multinational study organised by the International Agency for Research on Cancer (IARC), just one type, 16, is responsible for more than 50% of those cases. The study, which is published in the Journal of the National Cancer Institute (June 6th), found HPV DNA in 93% of more than 1,000 specimens of invasive cervical cancer collected from 22 countries with a high incidence of the disease over a three-year period.
You may also be interested in...
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.